Across TCGA patient cohorts, LINC01342 mutation is significantly associated with the RNA expression of many other genes, with 20 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LINC01342-associated genes across cancer lineages are NTAN1P1, MIR6803, and PRAMEF13. Each is linked with LINC01342 in more than 1 cancer types. Because this analysis shows association rather than direction, both LINC01342-to-partner and partner-to-LINC01342 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LINC01342→partner) and Y-score (partner→LINC01342) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	NTAN1P1 →	+0.192	+5.937	.005	.002	3	1
UCEC	MIR6803 →	+0.927	+8.478	<.001	<.001	3	1
UCEC	PRAMEF13 →	+0.093	+6.453	<.001	.001	3	1
UCEC	LINC01892 →	+0.210	+5.484	<.001	.005	3	1
UCEC	RNU6-338P →	+0.911	+5.031	<.001	.009	3	1
UCEC	RNU6-147P →	+0.579	+5.551	<.001	.004	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 20 associations by consensus.

Exploration

LINC01342 survival (RNA) · tumor vs normal (RNA) · all LINC01342 data types